| Course | NRNP 6539 Advanced Primary Care of Adults |
|---|---|
| Week | Week 3 |
| Paper type | Evaluation note |
| Length | About 910 words, 6 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | Master of Science in Nursing (MSN) |
| Updated | October 2026 |
Free sample paper for NRNP 6539 Week 3
Evaluation Note: Palpitations, Weight Loss, and a Gym Supplement in a 34-Year-Old Woman With Thyrotoxicosis
Student Name
College of Nursing, Walden University
NRNP 6539: Advanced Nurse Practice in Primary Care Adult Gerontology I
Instructor Name
Month Day, Year
Evaluation Note: Palpitations, Weight Loss, and a Gym Supplement in a 34-Year-Old Woman With Thyrotoxicosis
Subjective, by System
The patient is a composite: a 34-year-old elementary school teacher with three months of symptoms. Thyroid excess touches most systems, so the history is organized by them.
Cardiovascular: racing heart at rest and on climbing stairs, noticed when lying in bed. General and metabolic: 12 pounds lost despite eating more than usual; feels hot when others are comfortable and has switched to short sleeves in the fall. Gastrointestinal: stools looser and more frequent, two or three a day, without blood. Neurologic and psychiatric: hands shake when grading papers; feels anxious and irritable; sleeps poorly. Eyes: feel gritty and dry by evening; her husband says she "stares." Reproductive: periods lighter than usual. Respiratory: history of mild intermittent asthma, using an albuterol inhaler a few times a year.
Supplement: for four months she has taken a powdered "metabolism booster" from her gym, one scoop daily; she does not know its ingredients. Some supplements marketed for weight loss or energy have been found to contain thyroid hormone, so the product was photographed and its label reviewed; it lists a "thyroid support blend" without quantities. Other medications: none. Family history: her aunt has a thyroid condition, type unknown. No recent pregnancy, neck pain, or viral illness. No iodinated contrast or amiodarone.
Objective
Heart rate 112 at rest, regular; blood pressure 134/68; weight 131 lb, down from 143 lb in the record a year ago; temperature 99.1 F. A fine tremor is visible with her arms extended, and her skin is warm and damp. Eyes: lid lag on downward gaze, mild lid retraction, no proptosis, no chemosis, extraocular movements full without diplopia. Neck: thyroid smooth, diffusely enlarged to about twice normal size, nontender, without discrete nodules; a soft bruit over both lobes. Reflexes brisk. Lungs clear. Lid lag and a thyroid bruit are specific enough findings that they were sought deliberately rather than left to chance (Dains et al., 2020).
Laboratory values as supplied: TSH below the detection limit of the assay; free T4 3.4 ng/dL; total T3 elevated.
Assessment: Five Causes, Ranked
Biochemistry confirms overt thyrotoxicosis: a suppressed TSH with an elevated free T4 and T3.
1. Graves disease. For: a diffuse, symmetric goiter with a bruit, which reflects increased blood flow; eye findings of lid retraction and grittiness; young woman; family history of thyroid disease; three months of steady symptoms. Against: no proptosis, which is common but not required. In the United States, no cause of hyperthyroidism is more frequent than Graves disease (Ross et al., 2016).
2. Toxic multinodular goiter or toxic adenoma. For: thyrotoxicosis with an enlarged gland. Against: no palpable nodules, her age, and the bruit and eye findings favor Graves.
3. Painless (silent) thyroiditis. For: can cause a few months of thyrotoxicosis with a nontender gland. Against: typically a small or normal-sized gland without a bruit, and the symptoms are usually briefer.
4. Subacute (granulomatous) thyroiditis. For: thyrotoxicosis. Against: no neck pain or tenderness and no preceding viral illness; the gland is nontender.
5. Exogenous thyroid hormone from the supplement. For: an unlabeled supplement taken daily for four months. Against: exogenous hormone suppresses the gland, which would usually be small rather than enlarged with a bruit, and it does not cause eye findings. It stays on the list until the confirming test separates it, and she is asked to stop the product now regardless.
Plan
One confirming test: thyrotropin receptor antibody. A positive result confirms Graves disease and makes further imaging unnecessary in most cases; a negative result would prompt a radioactive iodine uptake scan, which would be high in toxic nodular disease and low in thyroiditis or exogenous hormone. The American Thyroid Association lists receptor antibody measurement, radioactive iodine uptake, and thyroid ultrasound with blood flow as acceptable approaches when the diagnosis is not clinically obvious (Ross et al., 2016).
Symptom control by drug class, after an asthma check: a beta-adrenergic blocker controls tachycardia, tremor, and anxiety while the cause is confirmed. Because she has asthma, a nonselective beta blocker is avoided, since blocking beta-2 receptors can provoke bronchospasm. Her asthma is mild and intermittent, so a beta-1 selective agent at a low dose is chosen with instructions to stop it and call if wheeze develops; if it is not tolerated, a nondihydropyridine calcium channel blocker is the alternative for rate control (Rosenthal & Burchum, 2021).
Stop the supplement and bring the container to the next visit.
Referral: endocrinology for definitive treatment options, which for Graves disease include antithyroid drugs, radioactive iodine, or surgery; she wants to discuss pregnancy plans in two years, which will affect that choice. Ophthalmology referral for her eye symptoms; lubricating drops meanwhile. She is advised not to smoke, which worsens thyroid eye disease.
What the results will change: if the receptor antibody is positive and she chooses antithyroid drug therapy with endocrinology, a baseline complete blood count and liver enzymes will be drawn first, because the drugs used can rarely cause agranulocytosis and liver injury, and she will be taught that fever or sore throat during treatment needs same-day evaluation. If testing points instead to thyroiditis or exogenous hormone, antithyroid drugs would not help and would not be used, and management would be symptom control while the thyroid function recovers on its own or after the supplement is stopped.
Follow-up: two weeks, sooner for fever, sore throat, chest pain, fainting, or confusion.
References
Dains, J. E., Baumann, L. C., & Scheibel, P. (2020). Advanced health assessment and clinical diagnosis in primary care (6th ed.). Elsevier.
Rosenthal, L. D., & Burchum, J. R. (2021). Lehne's pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.). Elsevier.
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., & Walter, M. A. (2016). 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid, 26(10), 1343-1421. https://doi.org/10.1089/thy.2016.0229
The Walden NRNP 6539 Week 3 instructions
The third week of NRNP 6539 often asks for an evaluation note on an endocrine presentation. You document a system-based history, a focused examination including the thyroid and eyes, interpret laboratory results, rank possible causes, and plan further testing and symptom management. Faculty reward restraint in naming the cause before confirming tests. The note runs a few pages and cites the ATA guideline in APA 7. Supplements and medications should be asked about. Medication doses may be left out. Referral criteria should be stated. NRNP 6539 instructors expect the eyes and thyroid examined and described in detail. Name each test and what result points to which cause. State whether beta blockade is appropriate for symptom control. Address pregnancy status for a woman of reproductive age. Note when endocrinology referral is warranted.
How the NRNP 6539 Week 3 example is put together
The history is organized by body system because thyroid excess touches most of them: racing heart at rest, weight loss despite a larger appetite, heat intolerance, looser stools, poor sleep, and eyes that feel gritty by evening. One detail matters more than it first seems: a powdered supplement from her gym, which the note flags because some such products contain thyroid hormone. The exam records resting tachycardia, a fine tremor, lid lag, and a smooth, diffusely enlarged, nontender gland. Her laboratory values are reported exactly as given, with no reference ranges restated. Five causes follow in ranked order, Graves disease first, then toxic nodular disease, painless thyroiditis, subacute thyroiditis, and exogenous hormone. The plan chooses one confirming test, controls symptoms by drug class after an asthma check, and refers for definitive therapy.
Where the marks sit in the NRNP 6539 Week 3 rubric
Credit here turns on restraint in naming the cause. A note that writes Graves disease in the assessment on the strength of a low TSH has matched a pattern, and the rubric for an endocrine week usually pays for the separation of causes, which is different reasoning. The supplement line tends to impress graders because it shows a medication history taken beyond prescriptions. Test selection is judged next: a full thyroid panel plus ultrasound plus uptake scan ordered together reads as uncertainty, whereas one discriminating test with a stated reason reads as judgment. Pharmacologic content loses points when a beta blocker appears without a check for reactive airway disease, and the plan loses more when referral is omitted or when definitive therapy is chosen without specialist input and without the ATA guidance cited.
NRNP 6539 Week 3 help from the desk
Thyroid notes lose credit when Graves disease is written in the assessment on the strength of a low TSH. Rank the causes and say what test will separate them. Another common gap is not asking about supplements, which can contain thyroid hormone. Writers also forget thyroiditis, which needs different treatment. Keep it on the list. Avoid prescribing antithyroid drugs before the cause is known. Keep laboratory values consistent through the note. Include beta blockade for symptoms if appropriate. Close with when results will be reviewed and when endocrinology is involved. Students also forget to bring the supplement bottle into the plan, asking the patient to stop it and bring it in. Add it. Another frequent gap is ignoring the heart rate and rhythm. Check for atrial fibrillation.
Get a NRNP 6539 Week 3 example written to your instructions
The desk needs three things for Week 3: the prompt, the rubric, and the endocrine case you were given, whether thyroid, adrenal, or diabetes. The note that returns separates causes before naming any and defends each test against its guideline. There is no charge for your first custom sample, and it arrives within 24-48 hours.
More NRNP 6539 papers and MSN samples
- NRNP 6539 Week 1: Adult Primary Care Post
- NRNP 6539 Week 2: Hyperlipidemia SOAP Note
- NRNP 6539 Week 4: COPD Exacerbation SOAP Note
- NRNP 6539 Week 5: CKD and Gout SOAP Note
- NRNP 6539 Week 6: Knee Imaging Discussion
- NRNP 6539 Week 7: Reflux Dyspepsia Note
- NRNP 6539 Week 8: Depression Screening Note
- NRNP 6539 Week 9: Health Maintenance Plan
- NRNP 6539 Week 10: Obesity Care Plan
- NRNP 6539 Week 11: Guideline Disagreement Replies
- NRNP 6540 Week 3: Post-Fall Evaluation Note
- NRNP 6537 Week 3: Respiratory Failure Note
- NRNP 6547 Week 3: Functional Assessment
- NRNP 6531 Week 3: Chronic Cough Differential
NRNP 6539 Week 3 questions, answered
Why not diagnose Graves disease from the eye symptoms?
Eye involvement makes Graves disease the leading candidate, which is why it ranks first, but gritty eyes are a soft finding and several causes of thyroid excess are treated very differently. The example keeps the alternatives on the list until a discriminating test is back. Rubrics in adult primary care tend to reward that discipline over a correct guess reached without it.
Does the note give medication doses?
The symptom-control option is named by drug class, beside the breathing history checked before it was chosen, and the definitive options carry the ATA citation. Numbers are left to the case. Where a rubric asks for a starting dose and a monitoring schedule, the sample supplies both with a source beside each, which is how this course expects dosing to appear.
Can the example serve a diabetes or adrenal case?
Its shape transfers: symptoms grouped by system, discriminating details pulled forward, one test argued rather than a panel ordered, and referral reasoned. The content does not. If your section assigned diabetes or another endocrine problem, send the case and a sample is built on it, with the guideline that governs that condition cited at each decision.
Where can I find a free NRNP 6539 Week 3 sample paper?
The thyrotoxicosis evaluation note is printed here with the system-based history, the five ranked causes and the testing plan, plus margin notes.
What did the history uncover in NRNP 6539 Week 3?
A gym supplement that may contain thyroid hormone, which keeps exogenous hormone on the list of causes.